20 June 2022 - The US FDA eliminated its backlog of overdue domestic pre-approval inspections, yet such progress has been ...
13 June 2022 - Following additional data submission to FDA demonstrating ORR superiority over ibrutinib as determined by IRC, PDUFA goal ...
10 June 2022 - The US FDA is quicker to approve new oncology drugs compared with the EMA, according to ...
7 June 2022 - NHS England and NICE asked for comments on our proposals for the Innovative Medicines Fund. ...
7 June 2022 - The most promising medicines will be fast-tracked to NHS patients through Innovative Medicines Fund ...
3 June 2022 - New PDUFA goal date scheduled for 29 September 2022 to allow time to review additional data ...
31 May 2022 - Efgartigimod was granted a promising innovative medicine designation by UK’s MHRA in November 2021. ...
31 May 2022 - New PDUFA goal date of 28 December 2022. ...
21 May 2022 - Innovation is the lifeblood that has made America the most economically successful nation in the modern era. ...
10 May 2022 - Amicus Therapeutics today announced that the U.S. FDA has extended the review period by 90 days ...
21 April 2022 - Medicines Australia has launched a social media campaign to highlight key policy issues for the election ...
14 April 2022 - Regeneron continues to progress its next generation antibodies, and has initiated a first in human trial. ...
11 April 2022 - Cancer patients in Ireland are waiting on average four months longer than people with the disease ...
11 April 2022 - Drug makers on Monday pledged to speed up the market launch of new drugs in underserved ...
10 April 2022 - With the Federal Election campaign now formally underway, Medicines Australia is reminding the major parties of ...